Answers are grounded in this paper and cite their sources.
Merging pharmacophores: Aggregation of the peptide amyloid-β (Aβ) is responsible for the development of Alzheimer's disease. Metal ions bound to Aβ can promote aggregation and oxidative stress, and can thus have a detrimental effect. Disruption of these processes with chelators, as well as targeting these chelators towards Aβ aggregates is therefore a promising strategy.
No takes yet. Share an insight, caveat, or question.
Hureau et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: